Stirling strengthens board

Listed biotechnology company Stirling Products has appointed Gunnar Aberg to its board. Dr Aberg is one of the inventors and patent holders of Stirling’s animal growth promoter. He is also the chief executive of Florida-based Bridge-Pharma, which is the largest shareholder in Stirling with 11 per cent of the equity.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
48 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer